Associated tags: Patient, McKesson Corporation, Pharmacy, Health, Pharmaceutical, MCK, NYSE, Medical Supplies, Biotechnology, Medical Devices, Supply Chain Management, General Health, Hospitals
Locations: CALIFORNIA, NEVADA, USA, SAN FRANCISCO, UNITED STATES, NORTH AMERICA, TEXAS, AVONDALE, OH
Retrieved on:
Wednesday, April 24, 2024
Medical Devices,
Medical Supplies,
Hospitals,
Health Technology,
Practice Management,
Biotechnology,
Health,
Pharmaceutical,
General Health,
McKesson Corporation,
MCK The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on July 1, 2024, to stockholders of record on June 3, 2024.
Key Points:
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on July 1, 2024, to stockholders of record on June 3, 2024.
Professional Services,
DEI (Diversity, Equity and Inclusion),
Health,
General Health,
Pharmaceutical,
Biotechnology,
Oasis,
McKesson Corporation,
Pharmacy,
Health equity,
Pharmacy (shop),
Health care McKesson Corporation today announced the launch of Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.
Key Points:
- McKesson Corporation today announced the launch of Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.
- Led by McKesson's Global Impact Organization and Community Pharmacy & Health, Project Oasis seeks to identify and address pharmacy deserts, particularly in urban areas where residents face significant challenges in accessing essential pharmacy services.
- After assessing numerous underserved communities across the nation, McKesson chose Avondale, OH, a neighborhood within Cincinnati, as the first activation site for Project Oasis.
- With the support of Project Oasis, Manny and Altev Community Pharmacy are now proudly serving Avondale and its residents and helping to tackle healthcare disparities.
Retrieved on:
Wednesday, March 27, 2024
McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024.
Key Points:
- McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024.
- The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
- The live webcast will be available on McKesson’s Investor Relations website at http://investor.mckesson.com , along with the company’s earnings release, financial tables and slide presentation.
Vitamins,
Supplements,
Other Retail,
Fitness & Nutrition,
Specialty,
Other Health,
Training,
Pharmaceutical,
Health,
Retail,
Education,
Community,
Conference,
Face,
Pharmacy,
Patient,
Head,
Knowledge,
Pharmacist,
McKesson Corporation,
Aluminium,
Nightclub The annual event is the destination for community pharmacists to come together to strengthen the overall health of pharmacy and elevate the role they play in people’s lives.
Key Points:
- The annual event is the destination for community pharmacists to come together to strengthen the overall health of pharmacy and elevate the role they play in people’s lives.
- McKesson ideaShare will culminate by celebrating the Health Mart Pharmacy of the Year ahead of a closing concert headlined by Harry Connick, Jr.
“New Orleans is known for its strength and resilience as is our community pharmacy industry.
- McKesson ideaShare’s collaborative environment will celebrate our industry while addressing key challenges head-on,” said Scott Miller, president, Strategic, Community, and Specialized Pharmacy, McKesson.
- This exclusive benefit is extended on behalf of McKesson to support independent pharmacy success in local communities across the U.S.
Retrieved on:
Thursday, February 8, 2024
Software,
Biotechnology,
Pharmaceutical,
Oncology,
Health,
Data Management,
Technology,
Health Insurance,
NCCN,
Mutation testing,
Targeted therapy,
National Comprehensive Cancer Network,
EHR,
Partnership,
MIPS,
GCSF,
Cancer,
CMS,
Medicare,
Innovation,
Physician,
Distress,
McKesson Corporation,
Patient,
MVP,
The Network,
Lung cancer,
Network For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR).
Key Points:
- For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-based Incentive Payment System (MIPS) as a Qualified Clinical Data Registry (QCDR).
- The designation enables healthcare practices and providers utilizing iKnowMed℠ electronic health record (EHR) to efficiently submit data directly to CMS without engaging a separate registry vendor, streamlining data submission and minimizing administrative burden.
- As a CMS-approved QCDR, Practice Insights ℠, a performance analytics tool powered by Ontada ®, can collect and report clinical data on behalf of clinicians for standard MIPS measures.
- It also continues to provide meaningful insights to improve care while simultaneously easing the burden of participating in CMS regulatory programs.
Retrieved on:
Wednesday, February 7, 2024
Medical Devices,
Medical Supplies,
Hospitals,
Health Technology,
Practice Management,
Biotechnology,
Health,
Pharmaceutical,
General Health,
McKesson Corporation,
MCK McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results.
Key Points:
- McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results.
- Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results .
- As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 7th at 4:30 PM ET to review its financial results.
- The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company’s earnings press release, financial tables, and slide presentation.
Retrieved on:
Thursday, February 1, 2024
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on April 1, 2024, to stockholders of record on March 1, 2024.
Key Points:
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on April 1, 2024, to stockholders of record on March 1, 2024.
Medical Supplies,
Health,
Logistics,
Supply Chain Management,
Transport,
Hospitals,
General Health,
Pharmaceutical,
Northwestern University,
MCK,
Compiler,
University,
Committee on Finance,
Kellogg School,
Acquisition,
Conference,
McKesson Corporation,
Audit committee,
Management McKesson Corporation (NYSE: MCK) will present at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT (12:45 PM ET).
Key Points:
- McKesson Corporation (NYSE: MCK) will present at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT (12:45 PM ET).
- The audio webcast will be available live at McKesson’s Investor Relations website at investor.mckesson.com , along with the company’s slide presentation.
- The McKesson board of directors has elected Kevin Ozan as director and member of the Audit Committee and Finance Committee, effective January 8, 2024.
- On January 4, 2024, McKesson acquired Compile, a healthcare data platform that aggregates and integrates data from across the US healthcare system to characterize providers and their patient panels.
Retrieved on:
Wednesday, December 27, 2023
Medical Supplies,
Health,
Transport,
Logistics,
Supply Chain Management,
Hospitals,
Pharmaceutical,
McKesson Corporation,
Conference,
MCK,
Cryptocurrency McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024.
Key Points:
- McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024.
- The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
- McKesson management will be participating in the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024.
- The live webcast for each event will be available on McKesson’s Investor Relations website at http://investor.mckesson.com , along with the company’s earnings release, financial tables and slide presentation.
Retrieved on:
Wednesday, December 13, 2023
Managed Care,
Biotechnology,
Pharmaceutical,
Health,
Elisabeth Lennartz,
Health Mart,
Master of Business Administration,
Policy,
Drake University,
Patient,
Strategic communication,
Business administration,
MBA,
Community Care,
Community,
Atlas,
Pharming,
McKesson Corporation,
Management,
Nursing,
Pharmacy McKesson appoints Crystal Lennartz, Pharm.D., MBA, to President of Health Mart ®, an independent pharmacy franchise, and Health Mart Atlas ™, a pharmacy services administrative organization (PSAO).
Key Points:
- McKesson appoints Crystal Lennartz, Pharm.D., MBA, to President of Health Mart ®, an independent pharmacy franchise, and Health Mart Atlas ™, a pharmacy services administrative organization (PSAO).
- As President, Lennartz will focus on strengthening the overall health of Health Mart and Health Mart Atlas pharmacy members and elevating the role they play in people’s lives.
- Most recently, she served as Vice President & General Manager, Health Mart Atlas & Atlas Specialty.
- Last year, she also led the development and implementation of Atlas Specialty, bringing the strength of Health Mart Atlas to support specialty pharmacies.
